CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 20 January 2015 |
| Author/s |
author: Steve Chan Alessandra Fabi Eva M Ciruelos Stefania Gori |
| Publication date | January 20, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |